SCHEMBL30338183

SCHEMBL30338183

CCCCCCCCC(CCCCCC)OC(=O)CCCCCCN(CCCCCCC(=O)OC(CCCCCC)CCCCCCCC)CCCn1ccnc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
KMT2A Q03164 3/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 3/20 0.40
MAPK1 P28482 3/20 0.40
LMNA P02545 5/20 0.38
TLR8 Q9NR97 2/20 0.36
PRKCA P17252 1/20 0.36
PRKCE Q02156 1/20 0.36
PRKCQ Q04759 1/20 0.36
PRKCD Q05655 1/20 0.36
GMNN O75496 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
MEN1 O00255 1/20 0.36
HSP90AA1 P07900 1/20 0.36
BLM P54132 1/20 0.36
NR1H4 Q96RI1 1/20 0.36
GLA P06280 1/20 0.36
PMP22 Q01453 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25125923 1.00 ALDH1A1 (0.46) ALDH1A1KMT2APOLBMAPTMAPK1
SCHEMBL23483339 0.99 ALDH1A1 (0.45) ALDH1A1KMT2APOLBMAPTMAPK1
SCHEMBL24002897 0.97 ALDH1A1 (0.43) ALDH1A1KMT2APOLBMAPTMAPK1
SCHEMBL23845983 0.97 ALDH1A1 (0.43) ALDH1A1KMT2APOLBMAPTMAPK1
SCHEMBL23483444 0.95 ALDH1A1 (0.42) ALDH1A1KMT2APOLBMAPTMAPK1
SCHEMBL24003188 0.95 ALDH1A1 (0.42) ALDH1A1KMT2APOLBMAPTMAPK1
SCHEMBL23461761 0.94 ALDH1A1 (0.41) ALDH1A1KMT2APOLBMAPTMAPK1
SCHEMBL23483280 0.94 ALDH1A1 (0.41) ALDH1A1KMT2APOLBMAPTMAPK1
SCHEMBL23483445 0.94 ALDH1A1 (0.40) ALDH1A1KMT2APOLBLMNAPRKCA
SCHEMBL24771055 0.93 ALDH1A1 (0.41) ALDH1A1KMT2APOLBMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250268828-A1 Lipid Nanoparticle Compositions for Delivering Circular Polynucleotides ORNA THERAPEUTICS, INC. 2025-08-28 US disclosed
EP-4408825-A1 LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERING CIRCULAR POLYNUCLEOTIDES Orna Therapeutics, Inc. (US) 2024-08-07 EP disclosed
WO-2023056033-A1 LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERING CIRCULAR POLYNUCLEOTIDES ORNA THERAPEUTICS, INC. (US) 2023-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250268828-A1 Lipid Nanoparticle Compositions for Delivering Circular Polynucleotides ABCB4, CETP, HDLBP ALDH1A1 4651/4885KMT2A 3198/4885POLB 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.